{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:46:35Z","timestamp":1792125995320,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77831-3","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:17:32Z","timestamp":1789553852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MAP2-mediated integrin dysregulation reprograms cancer cell plasticity in hepatocellular carcinoma"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-6287-4393","authenticated-orcid":false,"given":"Ut Kei","family":"Lou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-7958","authenticated-orcid":false,"given":"Tin-Lok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ianto Bosheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Hei","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huajian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Fong","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia Jian","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8821-8877","authenticated-orcid":false,"given":"Cheng-Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-7943","authenticated-orcid":false,"given":"Stephanie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"key":"77831_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"77831_CR2","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1038\/s43018-023-00595-y","volume":"4","author":"A P\u00e9rez-Gonz\u00e1lez","year":"2023","unstructured":"P\u00e9rez-Gonz\u00e1lez, A., B\u00e9vant, K. & Blanpain, C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nat. Cancer 4, 1063\u20131082 (2023).","journal-title":"Nat. Cancer"},{"key":"77831_CR3","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gutjnl-2021-324321","volume":"71","author":"L Zhou","year":"2022","unstructured":"Zhou, L. et al. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression. Gut 71, 1656\u20131668 (2022).","journal-title":"Gut"},{"key":"77831_CR4","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1097\/HEP.0000000000000269","volume":"78","author":"H Yu","year":"2023","unstructured":"Yu, H. et al. SERPINA12 promotes the tumorigenic capacity of HCC stem cells through hyperactivation of AKT\/\u03b2-catenin signaling. Hepatology 78, 1711\u20131726 (2023).","journal-title":"Hepatology"},{"key":"77831_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43670-9","volume":"14","author":"K Man","year":"2023","unstructured":"Man, K. et al. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma. Nat. Commun. 14, 7863 (2023).","journal-title":"Nat. Commun."},{"key":"77831_CR6","doi-asserted-by":"crossref","first-page":"e1440169","DOI":"10.1080\/2162402X.2018.1440169","volume":"7","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial. Oncoimmunology 7, e1440169 (2018).","journal-title":"Oncoimmunology"},{"key":"77831_CR7","doi-asserted-by":"crossref","first-page":"1846926","DOI":"10.1080\/2162402X.2020.1846926","volume":"9","author":"H Dai","year":"2020","unstructured":"Dai, H. et al. Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial. Oncoimmunology 9, 1846926 (2020).","journal-title":"Oncoimmunology"},{"key":"77831_CR8","doi-asserted-by":"crossref","first-page":"5479","DOI":"10.3390\/ijms23105479","volume":"23","author":"E Poonaki","year":"2022","unstructured":"Poonaki, E. et al. CD133-functionalized gold nanoparticles as a carrier platform for telaglenastat (CB-839) against tumor stem cells. Int J. Mol. Sci. 23, 5479 (2022).","journal-title":"Int J. Mol. Sci."},{"key":"77831_CR9","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1053\/j.gastro.2009.04.021","volume":"136","author":"RK Montgomery","year":"2009","unstructured":"Montgomery, R. K. & Shivdasani, R. A. Prominin1 (CD133) as an intestinal stem cell marker: promise and nuance. Gastroenterology 136, 2051\u20132054 (2009).","journal-title":"Gastroenterology"},{"key":"77831_CR10","doi-asserted-by":"crossref","unstructured":"Bakondi, B. et al. CD133 identifies a human bone marrow stem\/progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 17, 11 (2009).","DOI":"10.1038\/mt.2009.185"},{"key":"77831_CR11","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1172\/JCI42550","volume":"120","author":"N Haraguchi","year":"2010","unstructured":"Haraguchi, N. et al. CD13 is a therapeutic target in human liver cancer stem cells. J. Clin. Invest. 120, 3326\u20133339 (2010).","journal-title":"J. Clin. Invest"},{"key":"77831_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.molmed.2008.06.003","volume":"14","author":"P Mina-Osorio","year":"2008","unstructured":"Mina-Osorio, P. The moonlighting enzyme CD13: old and new functions to target. Trends Mol. Med. 14, 361\u2013371 (2008).","journal-title":"Trends Mol. Med"},{"key":"77831_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41392-021-00487-6","volume":"6","author":"JT Bulcha","year":"2021","unstructured":"Bulcha, J. T. et al. Viral vector platforms within the gene therapy landscape. Signal Transduct. Target Ther. 6, 53 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"77831_CR14","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-024-01808-1","volume":"9","author":"Y Xia","year":"2024","unstructured":"Xia, Y. et al. Drug repurposing for cancer therapy. Signal Transduct. Target Ther. 9, 92 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"77831_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0090-4295(84)80103-X","volume":"23","author":"NH Slack","year":"1984","unstructured":"Slack, N. H. & Murphy, G. P. Clinical toxicity and long-term results of Emcyt therapy for prostate cancer. Urology 23, 73\u201377 (1984).","journal-title":"Urology"},{"key":"77831_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/00002512-199507010-00006","volume":"7","author":"CM Perry","year":"1995","unstructured":"Perry, C. M. & McTavish, D. Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer. Drugs Aging 7, 49\u201374 (1995).","journal-title":"Drugs Aging"},{"key":"77831_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2004-6-1-204","volume":"6","author":"L Dehmelt","year":"2005","unstructured":"Dehmelt, L. & Halpain, S. The MAP2\/Tau family of microtubule-associated proteins. Genome Biol. 6, 204 (2005).","journal-title":"Genome Biol."},{"key":"77831_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cub.2004.01.058","volume":"14","author":"B Roger","year":"2004","unstructured":"Roger, B. et al. MAP2c, but not tau, binds and bundles F-actin via its microtubule binding domain. Curr. Biol. 14, 363\u2013371 (2004).","journal-title":"Curr. Biol."},{"key":"77831_CR19","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1093\/nar\/gkl476","volume":"34","author":"KMR Bhat","year":"2006","unstructured":"Bhat, K. M. R. et al. Transcriptional regulation of human MAP2 gene in melanoma: role of neuronal bHLH factors and Notch1 signaling. Nucleic Acids 34, 3819\u20133832 (2006).","journal-title":"Nucleic Acids"},{"key":"77831_CR20","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/neuonc\/nov060","volume":"17","author":"Y Zhou","year":"2015","unstructured":"Zhou, Y. et al. Transcriptional upregulation of microtubule-associated protein 2 is involved in the protein kinase A-induced decrease in the invasiveness of glioma cells. Neuro Oncol. 17, 1578\u20131588 (2015).","journal-title":"Neuro Oncol."},{"key":"77831_CR21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/hep.24736","volume":"55","author":"C Ho","year":"2012","unstructured":"Ho, C. et al. AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)\/SKP2, and c-Myc pathways. Hepatol. 55, 833\u2013845 (2012).","journal-title":"Hepatol"},{"key":"77831_CR22","doi-asserted-by":"crossref","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler, S. et al. A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70, 10202\u201310212 (2010).","journal-title":"Cancer Res"},{"key":"77831_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0596-9","volume":"16","author":"TB Toh","year":"2017","unstructured":"Toh, T. B., Lim, J. J. & Chow, E. K. Epigenetics in cancer stem cells. Mol. Cancer 16, 29 (2017).","journal-title":"Mol. Cancer"},{"key":"77831_CR24","doi-asserted-by":"crossref","unstructured":"Chen, J. et al. SETD1A drives stemness by reprogramming the epigenetic landscape in hepatocellular carcinoma stem cells. JCI Insight 8, e168375 (2023).","DOI":"10.1172\/jci.insight.168375"},{"key":"77831_CR25","doi-asserted-by":"crossref","unstructured":"Loh, J. J. et al. DGKH-mediated phosphatidic acid oncometabolism as a driver of self-renewal and therapy resistance in HCC. Hepatology 82, 308\u2013325 (2025).","DOI":"10.1097\/HEP.0000000000001158"},{"key":"77831_CR26","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/carcin\/bgac061","volume":"43","author":"L Huang","year":"2022","unstructured":"Huang, L. et al. SLC38A6, regulated by EP300-mediated modifications of H3K27ac, promotes cell proliferation, glutamine metabolism and mitochondrial respiration in hepatocellular carcinoma. Carcinogenesis 43, 885\u2013894 (2022).","journal-title":"Carcinogenesis"},{"key":"77831_CR27","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/hep.27968","volume":"62","author":"C Won","year":"2015","unstructured":"Won, C. et al. Signal transducer and activator of transcription 3-mediated CD133 up-regulation contributes to promotion of hepatocellular carcinoma. Hepatol. 62, 1160\u20131173 (2015).","journal-title":"Hepatol"},{"key":"77831_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nature24028","volume":"550","author":"LM Lasko","year":"2017","unstructured":"Lasko, L. M. et al. Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours. Nature 550, 128\u2013132 (2017).","journal-title":"Nature"},{"key":"77831_CR29","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/cr.2011.139","volume":"22","author":"Y Hou","year":"2012","unstructured":"Hou, Y. et al. The critical role of CD133(+)CD44(+\/high) tumor cells in hematogenous metastasis of liver cancers. Cell Res 22, 259\u2013272 (2012).","journal-title":"Cell Res"},{"key":"77831_CR30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.devcel.2019.04.010","volume":"49","author":"W Lu","year":"2019","unstructured":"Lu, W. & Kang, Y. Epithelial-mesenchymal plasticity in cancer progression and metastasis. Dev. Cell 49, 361\u2013374 (2019).","journal-title":"Dev. Cell"},{"key":"77831_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nature15260","volume":"526","author":"DA Lawson","year":"2015","unstructured":"Lawson, D. A. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells. Nature 526, 131\u2013135 (2015).","journal-title":"Nature"},{"key":"77831_CR32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673\u2013687 (2002).","journal-title":"Cell"},{"key":"77831_CR33","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccell.2019.01.007","volume":"35","author":"J Cooper","year":"2019","unstructured":"Cooper, J. & Giancotti, F. G. Integrin signaling in cancer: mechanotransduction, stemness, epithelial plasticity, and therapeutic resistance. Cancer Cell 35, 347\u2013367 (2019).","journal-title":"Cancer Cell"},{"key":"77831_CR34","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","volume":"29","author":"F Zanconato","year":"2016","unstructured":"Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP\/TAZ at the roots of cancer. Cancer Cell 29, 783\u2013803 (2016).","journal-title":"Cancer Cell"},{"key":"77831_CR35","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","volume":"147","author":"M Cordenonsi","year":"2011","unstructured":"Cordenonsi, M. et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell 147, 759\u2013772 (2011).","journal-title":"Cell"},{"key":"77831_CR36","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.30930","volume":"71","author":"Z Huang","year":"2020","unstructured":"Huang, Z. et al. PDLIM1 inhibits tumor metastasis through activating hippo signaling in hepatocellular carcinoma. Hepatology 71, 1643\u20131659 (2020).","journal-title":"Hepatology"},{"key":"77831_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41556-022-00848-5","volume":"24","author":"H Li","year":"2022","unstructured":"Li, H. et al. YAP\/TAZ drives cell proliferation and tumour growth via a polyamine-eIF5A hypusination-LSD1 axis. Nat. Cell Biol. 24, 373\u2013383 (2022).","journal-title":"Nat. Cell Biol."},{"key":"77831_CR38","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202114351","volume":"13","author":"R Gao","year":"2021","unstructured":"Gao, R. et al. YAP\/TAZ and ATF4 drive resistance to sorafenib in hepatocellular carcinoma by preventing ferroptosis. EMBO Mol. Med 13, e14351 (2021).","journal-title":"EMBO Mol. Med"},{"key":"77831_CR39","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0006-2952(91)90281-9","volume":"42","author":"B Frid\u00e9n","year":"1991","unstructured":"Frid\u00e9n, B., Rutberg, M., Deinum, J. & Wallin, M. The effect of estramustine derivatives on microtubule assembly in vitro depends on the charge of the substituent. Biochem Pharm. 42, 997\u20131006 (1991).","journal-title":"Biochem Pharm."},{"key":"77831_CR40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0167-4838(92)90342-B","volume":"1121","author":"D Moraga","year":"1992","unstructured":"Moraga, D. et al. Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau. Biochim Biophys. Acta 1121, 97\u2013103 (1992).","journal-title":"Biochim Biophys. Acta"},{"key":"77831_CR41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-5793(96)01524-4","volume":"403","author":"B Pedrotti","year":"1997","unstructured":"Pedrotti, B. & Islam, K. Estramustine phosphate but not estramustine inhibits the interaction of microtubule associated protein 2 (MAP2) with actin filaments. FEBS Lett. 403, 123\u2013126 (1997).","journal-title":"FEBS Lett."},{"key":"77831_CR42","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1442-2042.2010.02544.x","volume":"17","author":"Y Nakagami","year":"2010","unstructured":"Nakagami, Y. et al. Safety and efficacy of docetaxel, estramustine phosphate and hydrocortisone in hormone-refractory prostate cancer patients. Int J. Urol. 17, 629\u2013634 (2010).","journal-title":"Int J. Urol."},{"key":"77831_CR43","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/pros.2990050611","volume":"5","author":"T Kalland","year":"1984","unstructured":"Kalland, T. & Haukaas, S. A. Effects of diethylstilbestrol and estramustine phosphate (estracyt) on natural killer cell activity and tumor susceptibility in male mice. Prostate 5, 649\u2013660 (1984).","journal-title":"Prostate"},{"key":"77831_CR44","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jhep.2018.05.034","volume":"69","author":"M Tong","year":"2018","unstructured":"Tong, M. et al. Efficacy of annexin A3 blockade in sensitizing hepatocellular carcinoma to sorafenib and regorafenib. J. Hepatol. 69, 826\u2013839 (2018).","journal-title":"J. Hepatol."},{"key":"77831_CR45","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1200\/JCO.2017.73.8245","volume":"35","author":"KA Reiss","year":"2017","unstructured":"Reiss, K. A. et al. Starting Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study. J. Clin. Oncol. 35, 3575\u20133581 (2017).","journal-title":"J. Clin. Oncol."},{"key":"77831_CR46","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/nrd.2016.136","volume":"15","author":"Mullard","year":"2016","unstructured":"Mullard et al. Parsing clinical success rates. Nat. Rev. Drug Discov. 15, 447 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"77831_CR47","doi-asserted-by":"crossref","unstructured":"Wilson, M. R. et al. ARID1A mutations promote p300-dependent endometrial invasion through super-enhancer hyperacetylation. Cell Rep 33, 108366 (2020).","DOI":"10.1016\/j.celrep.2020.108366"},{"key":"77831_CR48","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/0008-5472.CAN-20-1323","volume":"81","author":"LY Cai","year":"2021","unstructured":"Cai, L. Y. et al. Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism. Cancer Res 81, 860\u2013872 (2021).","journal-title":"Cancer Res"},{"key":"77831_CR49","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/stem.1705","volume":"32","author":"F Fang","year":"2014","unstructured":"Fang, F. et al. Coactivators p300 and CBP maintain the identity of mouse embryonic stem cells by mediating long-range chromatin structure. Stem Cells 32, 1805\u20131816 (2014).","journal-title":"Stem Cells"},{"key":"77831_CR50","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.canlet.2011.06.030","volume":"310","author":"C Yokomizo","year":"2011","unstructured":"Yokomizo, C. et al. High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells. Cancer Lett. 310, 140\u2013147 (2011).","journal-title":"Cancer Lett."},{"key":"77831_CR51","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1083\/jcb.136.4.845","volume":"136","author":"CC Cunningham","year":"1997","unstructured":"Cunningham, C. C. et al. Microtubule-associated protein 2c reorganizes both microtubules and microfilaments into distinct cytological structures in an actin-binding protein-280-deficient melanoma cell line. J. Cell Biol. 136, 845\u2013857 (1997).","journal-title":"J. Cell Biol."},{"key":"77831_CR52","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.tcb.2022.09.009","volume":"33","author":"M Parlani","year":"2023","unstructured":"Parlani, M., Jorgez, C. & Friedl, P. Plasticity of cancer invasion and energy metabolism. Trends Cell Biol. 33, 388\u2013402 (2023).","journal-title":"Trends Cell Biol."},{"key":"77831_CR53","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1002\/hep.29678","volume":"67","author":"JM Peng","year":"2018","unstructured":"Peng, J. M. et al. Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology 67, 2226\u20132243 (2018).","journal-title":"Hepatology"},{"key":"77831_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nature10137","volume":"474","author":"S Dupont","year":"2011","unstructured":"Dupont, S. et al. Role of YAP\/TAZ in mechanotransduction. Nature 474, 179\u2013183 (2011).","journal-title":"Nature"},{"key":"77831_CR55","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.cell.2013.07.042","volume":"154","author":"M Aragona","year":"2013","unstructured":"Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP\/TAZ regulation by actin-processing factors. Cell 154, 1047\u20131059 (2013).","journal-title":"Cell"},{"key":"77831_CR56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4589","volume":"12","author":"MB Nilsson","year":"2020","unstructured":"Nilsson, M. B. et al. A YAP\/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components. Sci. Transl. Med 12, eaaz4589 (2020).","journal-title":"Sci. Transl. Med"},{"key":"77831_CR57","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s43018-024-00754-9","volume":"5","author":"EA Chapeau","year":"2024","unstructured":"Chapeau, E. A. et al. Direct and selective pharmacological disruption of the YAP-TEAD interface by IAG933 inhibits Hippo-dependent and RAS-MAPK-altered cancers. Nat. Cancer 5, 1102\u20131120 (2024).","journal-title":"Nat. Cancer"},{"key":"77831_CR58","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","volume":"295","author":"M Janiszewska","year":"2020","unstructured":"Janiszewska, M., Primi, M. C. & Izard, T. Cell adhesion in cancer: beyond the migration of single cells. J. Biol. Chem. 295, 2495\u20132505 (2020).","journal-title":"J. Biol. Chem."},{"key":"77831_CR59","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1158\/0008-5472.CAN-16-3240","volume":"77","author":"V Barton","year":"2017","unstructured":"Barton, V. et al. Androgen receptor supports an anchorage-independent, cancer stem cell-like population in triple-negative breast cancer. Cancer Res 77, 3455\u20133466 (2017).","journal-title":"Cancer Res"},{"key":"77831_CR60","doi-asserted-by":"crossref","first-page":"18126","DOI":"10.1073\/pnas.1409525111","volume":"111","author":"PJ Wrighton","year":"2014","unstructured":"Wrighton, P. J. et al. Signals from the surface modulate differentiation of human pluripotent stem cells through glycosaminoglycans and integrins. Proc. Natl. Acad. Sci. USA 111, 18126\u201318131 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77831_CR61","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41586-018-0762-2","volume":"564","author":"A Mamidi","year":"2018","unstructured":"Mamidi, A. et al. Mechanosignalling via integrins directs fate decisions of pancreatic progenitors. Nature 564, 114\u2013118 (2018).","journal-title":"Nature"},{"key":"77831_CR62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI42328","volume":"121","author":"NE Ramirez","year":"2011","unstructured":"Ramirez, N. E. et al. The \u03b1\u2082\u03b2\u2081 integrin is a metastasis suppressor in mouse models and human cancer. J. Clin. Invest 121, 226\u2013237 (2011).","journal-title":"J. Clin. Invest"},{"key":"77831_CR63","doi-asserted-by":"crossref","first-page":"4954","DOI":"10.1002\/jcp.30202","volume":"236","author":"Z Salemi","year":"2021","unstructured":"Salemi, Z., Azizi, R., Fallahian, F. & Aghaei, M. Integrin \u03b12\u03b21 inhibition attenuates prostate cancer cell proliferation by cell cycle arrest, promoting apoptosis and reducing epithelial-mesenchymal transition. J. Cell Physiol. 236, 4954\u20134965 (2021).","journal-title":"J. Cell Physiol."},{"key":"77831_CR64","doi-asserted-by":"crossref","unstructured":"Truong, H. H. et al. \u03b21 integrin inhibition elicits a prometastatic switch through the TGF\u03b2-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. Sci. Signal 7, ra15 (2014).","DOI":"10.1126\/scisignal.2004751"},{"key":"77831_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-019-1146-8","volume":"21","author":"V Ramovs","year":"2019","unstructured":"Ramovs, V. et al. Absence of integrin \u03b13\u03b21 promotes the progression of HER2-driven breast cancer in vivo. Breast Cancer Res 21, 63 (2019).","journal-title":"Breast Cancer Res"},{"key":"77831_CR66","doi-asserted-by":"crossref","first-page":"6577","DOI":"10.1158\/0008-5472.CAN-16-1483","volume":"76","author":"A Varzavand","year":"2016","unstructured":"Varzavand, A. et al. \u03b13\u03b21 Integrin suppresses prostate cancer metastasis via regulation of the Hippo pathway. Cancer Res 76, 6577\u20136587 (2016).","journal-title":"Cancer Res"},{"key":"77831_CR67","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-17-2867","volume":"78","author":"YL Zhang","year":"2018","unstructured":"Zhang, Y. L. et. al. SPON2 promotes M1-like macrophage recruitment and inhibits hepatocellular carcinoma metastasis by distinct integrin-Rho GTPase-hippo pathways. Cancer Res 78, 2305\u20132317 (2018).","journal-title":"Cancer Res"},{"key":"77831_CR68","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch, M. et al. Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299\u2013312 (2015).","journal-title":"Cell"},{"key":"77831_CR69","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1172\/JCI78585","volume":"125","author":"S J\u00f6rs","year":"2015","unstructured":"J\u00f6rs, S. et al. Lineage fate of ductular reactions in liver injury and carcinogenesis. J. Clin. Invest 125, 2445\u20132457 (2015).","journal-title":"J. Clin. Invest"},{"key":"77831_CR70","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.ajpath.2013.12.002","volume":"184","author":"X Chen","year":"2014","unstructured":"Chen, X. & Calvisi, D. F. Hydrodynamic transfection for generation of novel mouse models for liver cancer research. Am. J. Pathol. 184, 912\u2013923 (2014).","journal-title":"Am. J. Pathol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77831-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77831-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:10:28Z","timestamp":1792123828000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77831-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77831"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77831-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"27 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10866"}}